The Invesco QQQ Income Advantage ETF offers an 8.63% yield from option strategies in the Nasdaq 100. QQA has 3/4 of assets in Nasdaq 100 stocks and delegates option income generation to equity-linked notes. QQA's short track record shows a total return nearly matching QQQ, but the price return is flat.
SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced that the Compensation Committee of Gossamer's Board of Directors approved the grant, effective June 5th, 2025, to three non-executive employees of non-qualified stock op.
MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of up to 71,275 shares of common stock. Awards were made to seven new employees of the Company. The awards were granted as an inducement material to the new employees becoming employees of the Company in accordance with Nasdaq Listing Rule 5635(c)(4) and have been approved by the Company's Compensation Committ.
![]() NAQ 2 months ago | Other | €0.21 Per Share |
![]() NAQ 6 months ago | Other | €0.21 Per Share |
![]() NAQ 8 months ago | Other | €0.21 Per Share |
![]() NAQ 11 months ago | Other | €0.21 Per Share |
![]() NAQ 13 Mar 2024 | Other | €0.19 Per Share |
23 Jul 2025 (46 Days) Date | | - Cons. EPS | - EPS |
23 Apr 2025 Date | | - Cons. EPS | - EPS |
29 Jan 2025 Date | | - Cons. EPS | - EPS |
24 Oct 2024 Date | | - Cons. EPS | - EPS |
16 Oct 2024 Date | | - Cons. EPS | - EPS |
![]() NAQ 2 months ago | Other | €0.21 Per Share |
![]() NAQ 6 months ago | Other | €0.21 Per Share |
![]() NAQ 8 months ago | Other | €0.21 Per Share |
![]() NAQ 11 months ago | Other | €0.21 Per Share |
![]() NAQ 13 Mar 2024 | Other | €0.19 Per Share |
23 Jul 2025 (46 Days) Date | | - Cons. EPS | - EPS |
23 Apr 2025 Date | | - Cons. EPS | - EPS |
29 Jan 2025 Date | | - Cons. EPS | - EPS |
24 Oct 2024 Date | | - Cons. EPS | - EPS |
16 Oct 2024 Date | | - Cons. EPS | - EPS |
Financial - Data & Stock Exchanges Industry | Financial Services Sector | Ms. Adena T. Friedman CEO | XSTU Exchange | US6311031081 ISIN |
US Country | 9,377 Employees | 14 Mar 2025 Last Dividend | 29 Aug 2022 Last Split | 1 Jul 2002 IPO Date |
Nasdaq, Inc. is a global technology company that serves capital markets and a variety of other industries, marking its presence worldwide. The company operates across three primary segments: Capital Access Platforms, Financial Technology, and Market Services. Initially known as The NASDAQ OMX Group, Inc., the company underwent a name change to Nasdaq, Inc. in September 2015, continuing its legacy since its inception in 1971. With its headquarters located in New York, New York, Nasdaq, Inc. has been at the forefront of providing innovative financial products, technology solutions, and market services designed to enhance the efficiency and transparency of the capital markets.
This segment is integral to Nasdaq's offerings, focusing on the distribution of historical and real-time market data. It encompasses developing and licensing Nasdaq-branded indices and financial products, providing investor relations intelligence, governance solutions, ESG solutions, insights, and workflow solutions. It also includes the operation of listing platforms, making it a crucial component for enterprises seeking capital market access and compliance.
Nasdaq's Financial Technology segment presents a range of solutions aimed at combating financial fraud and enhancing regulatory compliance, including:
The Market Platforms segment of Nasdaq, Inc. provides a variety of trading and clearing services across multiple asset classes. These include: